Komombo speeds up lPF diagnosis
Komombo is committed to AI to speed up the diagnosis of lung diseases among Hospital Clinic of Barcelona and Enzyme Advising Group.
20 DE SEPTIEMBRE DE 2022.
Hospital Clínic of Barcelona (HCB), recognized as the best hospital in Spain and ranked 21st
in the world, and the “Fundació Clínic per a la Recerca Biomèdica”, have signed a research
and strategic development agreement with Enzyme Advising Group that aims to develop
artificial intelligence algorithms to accelerate the diagnosis of lung diseases.
The initial project will focus on improving, using artificial intelligence and computer vision, the diagnosis of a chronic disease that affects both lungs diffusely and is characterized by progressive scarring that causes the lung to lose flexibility, and performance deteriorates over time.